Karen Nelson

Karen Nelson

Auto-generated profile, based on publicly available information

Karen Nelson

Bloodworks Northwest, Seattle, Washington

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2013 in Transplantation
Verified
Journal Article
Open access
NLNicolae Leca
Nicolae Leca
PWPaul Warner
Paul Warner
RBRamaswamy Bakthavatsalam
Ramaswamy Bakthavatsalam
KNKaren Nelson
Karen Nelson
JHJeffrey Halldorson
Jeffrey Halldorson
JRJorge Reyes
Jorge Reyes
The protective effect of the liver allograft when simultaneously transplanted with a kidney in the setting of allosensitization is unclear. We analyzed the significance of sensitization, defined based on positive cytotoxicity crossmatches, positive flow cytometry crossmatches, and/or the presence of high levels of donor-specific antibodies, on the outcomes of simultaneous liver and kidney (SLK) transplantation. We reviewed 56 SLK performed at our center through December 31, 2011 and identified 13 patients who met high sensitization criteria. Median patient survival was not significantly different: 86 months (95% confidence interval [CI], 47-135) for nonsensitized patients versus 151 months (95% CI, 4 to ∞) for sensitized patients (P=0.5). The 5-year survival was 67% (95% CI, 0.5-0.8) in the nonsensitized group and 64% (95% CI, 0.3-0.9) in the sensitized group. There were six renal allograft failures in the nonsensitized group but none in the sensitized group. The adjusted hazard ratios associated with the risk of death or the combined risk of death or renal allograft failure were 0.7 (95% CI, 0.1-3.8) and 0.4 (95% CI, 0.1-2.2) for sensitized versus nonsensitized patients. There were significantly more renal allograft rejections in the sensitized group (5 vs. 1; P=0.002) in the first year after transplantation, only one showing C4d positivity. Creatinine levels at 1 year after transplantation were similar: 1.5 mg/dL in the nonsensitized group versus 1.36 mg/dL in the sensitized group (P=0.6). Sensitization does not appear to have a significant negative impact on the survival of SLK patients.

1 December 2005 in Cell and Tissue Banking
Verified
Journal Article
Closed access
PDF file
DSD. Michael Strong
D. Michael Strong
KNKaren Nelson
Karen Nelson
MPMarge Pierce
Marge Pierce
SSSusan L. Stramer
Susan L. Stramer

13 October 2019 in Transfusion
Verified
Journal Article
Closed access
PDF file
KNKaren A. Nelson
Karen A. Nelson
GAGabriel S. Aldea
Gabriel S. Aldea
PWPaul Warner
Paul Warner
YLYvette Latchman
Yvette Latchman
DGDevi Gunasekera
Devi Gunasekera
SSSherrill J. Slichter
Sherrill J. Slichter

16 September 2010 in Human Immunology
Verified
Journal Article
Closed access
JSJodi Smith
Jodi Smith
KNKaren Nelson
Karen Nelson
PWPaul Warner
Paul Warner
DYDanny Youngs
Danny Youngs
RMRuth McDonald
Ruth McDonald

29 July 2018
Verified
Book Chapter
Closed access
PDF file
IGIdoia Gimferrer
Idoia Gimferrer
KNKaren A. Nelson
Karen A. Nelson

15 July 2014 in Transplantation
Verified
Journal Article
Open access
JSJ. Smith
J. Smith
KNK. Nelson
K. Nelson
PWP. Warner
P. Warner
LFL. Finn
L. Finn
HPH. Pope
H. Pope
RMR. McDonald
R. McDonald